Orbsen Therapeutics Limited
Biotechnology Research • 
Galway, Co Galway, Ireland • 11-20 Employees
Company overview
| Headquarters | Galway, Co Galway, Ireland |
| Phone number | +35391528778 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Cell Therapy, Stem Cell Research, Stem Cell Therapy, Stem Cell Isolation |
| Founded | 2006 |
| Employees | 11-20 |
| Socials |
Key Contact at Orbsen Therapeutics Limited
James F X Fahy
Director- One Of 4 Founding Directors
Orbsen Therapeutics Limited Email Formats
Orbsen Therapeutics Limited uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@orbsentherapeutics.com), used 57.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}.{last name} | j.doe@orbsentherapeutics.com | 57.1% |
{first name}.{last name} | john.doe@orbsentherapeutics.com | 42.9% |
About Orbsen Therapeutics Limited
Orbsen Therapeutics Limited aims to become a leading company in the development of regenerative medicine therapies across a range of diseases and medical conditions. We are developing a novel proprietary technology that permits the isolation of pure and defined stomal cells from human tissue and a range of other species. The multi-species elements allow our technology to move seamlessly from the research laboratories to the clinic. The technology is designed to ensure that resulting therapies comply with the forthcoming stringent EMA and UK BSI guidelines regarding the purity and definition of cellular therapies. We believe that our technology will set the standard for regenerative medicine into the future. Orbsen Therapeutics was originally formed in 2006 as a spin out company from REMEDI, Ireland's Regenerative Medicine Institute in NUI Galway. Founded and led by some of the leading scientists in the field of regenerative medicine we operate from within the Orbsen Building, on campus at NUI Galway, which houses REMEDI's state of the art research facilities. The company has already participated in EU FP7 funded research progammes and has a significant research pipeline coming to fruition over the coming years.
Orbsen Therapeutics Limited revenue & valuation
| Annual revenue | $7,500,000 |
| Revenue per employee | $682,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $24,000,000 |
| Total funding | $1,300,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Orbsen Therapeutics Limited has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Explore Orbsen Therapeutics Limited's funding history, including investment rounds, total capital raised, and key backers.
Orbsen Therapeutics Limited Tech Stack
Discover the technologies and tools that power Orbsen Therapeutics Limited's digital infrastructure, from frameworks to analytics platforms.
Security
Video players
JavaScript libraries
Maps
JavaScript libraries
JavaScript libraries
CDN
JavaScript libraries
Miscellaneous
Programming languages
Blogs
UI frameworks
Japan
Frequently asked questions
4.8
40,000 users
